Section Review Oncologic, Endocrine & Metabolic: Recent developments with novel anthracyclines for the treatment of haematological malignancies

This publication has 16 references indexed in Scilit:

• Influence of idarubicinol on the antileukemic effect of idarubicin
  Leukemia Research, 1994
• Clinical Pharmacokinetics of Idarubicin
  Clinical Pharmacokinetics, 1993
• Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts
  Japanese Journal of Cancer Research, 1989
• Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds
  The Journal of Organic Chemistry, 1987
• Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action
  Biochemistry, 1987
• A phase I study of menogaril in patients with advanced cancer.
  Journal of Clinical Oncology, 1987
• Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
  Annals of Internal Medicine, 1979
• Daunomycin-induced cardiotoxicity in children and adults: A review of 110 cases
  Published by Elsevier ,1977
• Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
  Biotechnology & Bioengineering, 1969
• ‘Daunomycin’, a New Antibiotic of the Rhodomycin Group
  Nature, 1964